Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.
Kachnic LA, Winter K, Suntharalingam M, Ilson D, Konski A, Lloyd S, McAvoy SA, Lad T, Olowokure OG, Samson P, Gore EM, Meyer JE, Videtic GMM, Clump DA, Raben A, Kayaleh O, Barker J Jr, Haddock MG, Hopkins JO, Bruner DW.
Kachnic LA, et al. Among authors: meyer je.
Qual Life Res. 2024 Oct;33(10):2833-2844. doi: 10.1007/s11136-024-03736-7. Epub 2024 Jul 27.
Qual Life Res. 2024.
PMID: 39066879
Free PMC article.
Clinical Trial.